Reporting to the VP of Clinical Pharmacology, this role will provide strategic leadership and serve as an independent subject matter expert, shaping dose selection, exposure–response strategy, and overall clinical pharmacology plans, while also contributing hands-on analyses across the portfolio. In the near term, the role will focus on leading clinical pharmacology strategy, study design, modeling & simulation, and CRO oversight for active clinical programs, ensuring regulatory alignment and submission readiness.